THOR Shares Outstanding History
Below is a table of the THOR shares outstanding history going back to 12/7/2018:

Date THOR Shares Outstanding

Also see: THOR Market Cap History
THOR Historical Shares Outstanding:
+20.03% CAGR
THOR Historical Shares Outstanding: +20.03% CAGR

Mouse over chart for data details
12/7/2018 ...10/31/2019
Synthorxis is a biopharmaceutical company. Co.'s platform technology expands the genetic code by adding a DNA base pair and is designed to create optimized biologics, which it refers to as Synthorins. Co.'s main product candidate, THOR-707, is a variant of innate lymphoid (IL)-2 designed to kill tumor cells by increasing CD8+ T and natural killer cells without causing vascular leak syndrome observed with approved recombinant IL-2 (aldesleukin). Co.'s second IL-2 program is focused on autoimmune disorders based on the observation that low doses of IL-2 can dampen immune cell activation through selective proliferation of CD4+ regulatory T cells. Co. is developing an IL-2 autoimmune Synthorin. We show 5 historical shares outstanding datapoints in our coverage of THOR's shares outstanding history.

Understanding the changing numbers of THOR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like THOR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching THOR by allowing them to research THOR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree THOR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Synthorx (THOR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

THRD Shares Outstanding History
THRN Shares Outstanding History
THRX Shares Outstanding History
TIL Shares Outstanding History
TIVC Shares Outstanding History
TKNO Shares Outstanding History
TLGT Shares Outstanding History
TLIS Shares Outstanding History
TLRY Shares Outstanding History
TMCI Shares Outstanding History
More Healthcare companies »


THOR Shares Outstanding History | | Copyright © 2017 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.